International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Swati Naik(St. Jude Children's Research Hospital), Saar Gill(Parker Institute for Cancer Immunotherapy), Marco Becilli(Bambino Gesù Children's Hospital), Franco Locatelli(Bambino Gesù Children's Hospital), Mireya Paulina Velasquez(St. Jude Children's Research Hospital), David A. Sallman(Moffitt Cancer Center), Nirali N. Shah(National Institutes of Health), Sarah Tettamanti(Azienda Ospedaliera San Gerardo), Richard Aplenc(Children's Hospital of Philadelphia), Alexandra Dreyzin(National Cancer Institute), Concetta Quintarelli(Bambino Gesù Children's Hospital), Adam J. Lamble(Seattle Children's Hospital), Bilal Omer(Baylor College of Medicine), Rebecca M. Richards(Stanford University), Anthony F. Daniyan(Memorial Sloan Kettering Cancer Center), Challice L. Bonifant(Johns Hopkins University), LaQuisa C. Hill(Baylor College of Medicine), Stephen Gottschalk(St. Jude Children's Research Hospital), Susanne H.C. Baumeister(Dana-Farber Cancer Institute), Sarah K. Tasian(Children's Hospital of Philadelphia), M. Eric Kohler(University of Colorado Denver), Corinne Summers(Seattle Children's Hospital), Anand Bhagwat(Children's Hospital of Philadelphia), Sara Ghorashian(Great Ormond Street Hospital), Benedetta Rambaldi(Harvard University), Rebecca Gardner(Seattle Children's Hospital), Lihua E. Budde(City Of Hope National Medical Center), Maksim Mamonkin(Houston Methodist), Tim Sauer(Heidelberg University), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Naomi Taylor(National Institutes of Health), Christopher D. Chien, Michael R. Verneris(NHS Blood and Transplant)
Cited by 7
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k